Karen L. Smith is Director at ACCELERON PHARMA INC (XLRN). They have made 7 open-market trades across 3 companies since 2016, most recently 2025-06-12.
CIK 0001639637
4 open-market purchases totalling $583K since 2016, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AUPH | SELL | 2024-11-11 | 2024-11-12 | $8.43 | $44K | +5.1% | +14.9% | -5.5% |
| XLRN | SELL | 2021-04-05 | 2021-04-05 | $140.19 | $3.3M | -10.5% | -12.4% | -8.3% |
| XLRN | SELL | 2021-04-01 | 2021-04-02 | $136.47 | $2.4M | -12.1% | -10.4% | -7.4% |
| JAZZ | BUY | 2016-08-12 | 2016-08-12 | $137.10 | $167K | -4.8% | -11.1% | -16.2% |
| JAZZ | BUY | 2016-08-12 | 2016-08-12 | $137.10 | $83K | -4.8% | -11.1% | -16.2% |
| JAZZ | BUY | 2016-07-13 | 2016-07-13 | $143.63 | $167K | -1.3% | -4.6% | -14.5% |
| JAZZ | BUY | 2016-06-13 | 2016-06-15 | $149.61 | $167K | -9.9% | -3.3% | -18.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.